ATLANTA--(BUSINESS WIRE)--AerovectRx Corporation, developer of new unit dose aerosol drug delivery technology, today announced that Jonathan Mow has joined the company’s board of directors. Mr. Mow has extensive experience in pharmaceutical marketing and business development, with his last two companies focusing on the development and commercialization of aerosol drugs.
